PNC vs PTGX · P/E 14, rev $6.88B vs rev $269.8M
PNC Financial Services Group Inc (PNC) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported PNC revenue for 2026-06-30 was $6.88B. Net income was $2.04B. Revenue was up 11.5% from 2026-03-31 to 2026-06-30. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
PNC currently screens at market cap $77.76B and trailing P/E 13.9. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the PNC and PTGX stock pages for the full models.
Not investment advice.